Updated: January 12, 2026
How Does Emsam Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
How does the Emsam selegiline patch actually work to treat depression? Here's a clear explanation of its mechanism of action and why it's different from SSRIs.
Emsam (selegiline transdermal system) works differently from most antidepressants you may have heard of. Unlike SSRIs like Prozac or SNRIs like Effexor, which work by preventing neurotransmitters from being reabsorbed, Emsam works by blocking the enzyme that destroys them in the first place. Understanding this distinction helps explain both why Emsam works for patients who haven't responded to other antidepressants and why it has unique safety considerations.
The Role of Monoamine Oxidase in Depression
To understand how Emsam works, you first need to understand monoamine oxidase (MAO). MAO is an enzyme — a biological machine in your body — whose job is to break down neurotransmitters after they've done their job. The key neurotransmitters MAO targets are:
Serotonin — Regulates mood, sleep, and appetite
Norepinephrine — Involved in alertness, energy, and the stress response
Dopamine — Affects motivation, pleasure, and reward
In depression, the brain often has insufficient activity of these neurotransmitters. One reason may be that MAO is breaking them down too quickly. Blocking MAO keeps these mood-regulating chemicals available in the brain for longer — which is the core idea behind monoamine oxidase inhibitors (MAOIs) like Emsam.
MAO-A vs. MAO-B: What's the Difference?
MAO comes in two forms — MAO-A and MAO-B — which are found in different concentrations in different parts of the body:
MAO-A — Found primarily in the gut and liver; breaks down serotonin, norepinephrine, and dietary tyramine
MAO-B — Found primarily in the brain; breaks down dopamine and phenylethylamine
Selegiline (the active drug in Emsam) has a natural preference for MAO-B. At low doses used for Parkinson's disease (taken orally), it selectively inhibits only MAO-B. But at the antidepressant doses delivered by the Emsam patch, selegiline inhibits both MAO-A and MAO-B in the brain — which is necessary for the full antidepressant effect.
Why the Patch Is Different From Oral MAOIs
This is where Emsam's transdermal delivery system becomes a genuine innovation. Here's the key:
When you take an oral MAOI tablet, the drug first passes through your digestive tract before reaching the brain. In the gut, selegiline inhibits MAO-A — the very enzyme responsible for breaking down tyramine from food. When this gut MAO-A is blocked, tyramine from foods like aged cheese, cured meats, and wine can flood the bloodstream, causing blood pressure to spike to dangerous levels. This is the infamous "cheese reaction" or tyramine hypertensive crisis.
Emsam's patch route bypasses the digestive system entirely. The drug is absorbed through the skin directly into the bloodstream and goes to the brain — but at the 6 mg/24hr starting dose, enough intestinal MAO-A activity is preserved that tyramine from food can still be metabolized normally. This is why:
At 6 mg/24hr: No dietary restrictions are required — a unique advantage over all oral MAOIs
At 9 mg and 12 mg/24hr: Higher doses do inhibit gut MAO-A, so tyramine dietary restrictions are required at these doses
How Emsam Compares to SSRIs and SNRIs
SSRIs (like fluoxetine/Prozac, sertraline/Zoloft) and SNRIs (like venlafaxine/Effexor, duloxetine/Cymbalta) work by blocking the transporter proteins that reabsorb serotonin and norepinephrine back into neurons after release. This keeps those neurotransmitters in the synapse longer.
Emsam works at a completely different point in the process: it prevents the enzyme from destroying the neurotransmitters after they've been reabsorbed. This upstream effect on the enzyme system means that Emsam can produce antidepressant effects through mechanisms that SSRIs and SNRIs don't touch — which is why it can work in patients who haven't responded to multiple other antidepressants.
Why Does Emsam Work on Dopamine When Most Antidepressants Don't?
Most standard antidepressants (SSRIs, SNRIs) primarily affect serotonin and/or norepinephrine. Because Emsam inhibits both MAO-A and MAO-B in the brain, it also significantly increases dopamine levels. This is thought to be important in treating anhedonia (loss of pleasure), lack of motivation, fatigue, and cognitive symptoms of depression — areas where SSRIs and SNRIs are often less effective.
This dopaminergic action is also why Emsam shares its active ingredient (selegiline) with Parkinson's medications — Parkinson's is fundamentally a disease of dopamine deficiency.
The Irreversible Nature of MAOI Inhibition
An important pharmacological feature of Emsam is that its MAO inhibition is irreversible. Selegiline permanently binds to and inactivates MAO enzymes. This means that even after you remove the last Emsam patch, the MAO inhibition continues for up to 14 days while your body generates new MAO enzymes.
This is why there is a 14-day washout period required before starting other antidepressants after stopping Emsam — the drug is still active in your body even when no new doses are being applied.
For a complete list of drugs that interact with Emsam due to its mechanism of action, see our guide: Emsam Drug Interactions: What to Avoid.
If you've been prescribed Emsam and need to locate it at a pharmacy near you, medfinder can help you find which pharmacies carry it in your area.
Frequently Asked Questions
SSRIs work by blocking the reuptake of serotonin into neurons, keeping it active in the synapse longer. Emsam works by inhibiting the enzyme monoamine oxidase (MAO), which breaks down serotonin, norepinephrine, and dopamine after they've been reabsorbed. These are fundamentally different mechanisms, which is why Emsam can work for patients who haven't responded to SSRIs or SNRIs.
Emsam inhibits both MAO-A and MAO-B in the brain at antidepressant doses. MAO-B is the primary enzyme responsible for breaking down dopamine. By inhibiting MAO-B, Emsam increases dopamine levels — which most SSRIs and SNRIs don't do. This dopaminergic effect may explain Emsam's usefulness in patients with prominent anhedonia, low motivation, and fatigue.
Selegiline permanently binds to and inactivates MAO enzymes rather than temporarily blocking them. This means the effect continues even after the medication is stopped — for up to 14 days — until your body produces new MAO enzymes. This is why a 2-week washout period is required before starting other serotonergic medications after stopping Emsam.
At 6 mg/24hr, the transdermal delivery route bypasses the digestive tract, sparing enough intestinal MAO-A enzyme activity to properly metabolize dietary tyramine. At higher doses (9 and 12 mg/24hr), more MAO-A in the gut is inhibited, creating the risk of tyramine-induced hypertensive crisis — which is why dietary restrictions become necessary at those doses.
Yes. Oral selegiline is also used for Parkinson's disease (under the brand Eldepryl). At low oral doses, selegiline selectively inhibits MAO-B and increases dopamine levels — which helps with Parkinson's motor symptoms. The Emsam patch uses higher doses that also inhibit MAO-A, which adds serotonin and norepinephrine effects necessary for antidepressant activity.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Emsam also looked for:
More about Emsam
35,524 have already found their meds with Medfinder.
Start your search today.





